WHO implements fee changes to its Prequalification of Medicines Program

10 September 2013

Fee changes have come into force in the World Health Organization Prequalification of Medicines Program (PQP), with the WHO now planning to charge applicants for their submissions.

The PQP was originally intended to give United Nations procurement agencies, such as UNICEF, a choice of quality medicines. The program supplements its internal expertise with experts from national regulatory authorities to provide a list of prequalified medicines that comply with accepted international standards.

The externally-funded program was previously able to fund its activities through donor organizations. But in a message to supporters the WHO said that the current economic climate means it “can no longer afford to rely solely on donor funding for our on-going financial viability.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical